Cargando…
Development and internal validation of a screening tool for chronic prostatitis (S-CP)
PURPOSE: We developed a simple self-checkable screening tool for chronic prostatitis (S-CP) and internally validated it to encourage men (in the general population) with possible chronic prostatitis to consult urologists. METHODS: The expert panel proposed the S-CP, which comprises three domains: Ar...
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10582131/ https://www.ncbi.nlm.nih.gov/pubmed/37712967 http://dx.doi.org/10.1007/s00345-023-04574-x |
_version_ | 1785122262029959168 |
---|---|
author | Tohi, Yoichiro Hijikata, Yasukazu Sugimoto, Mikio Kuroda, Hideya Takei, Mineo Matsuki, Takakazu Kamitani, Tsukasa Kakehi, Yoshiyuki Fukuhara, Shunichi Yamamoto, Yosuke |
author_facet | Tohi, Yoichiro Hijikata, Yasukazu Sugimoto, Mikio Kuroda, Hideya Takei, Mineo Matsuki, Takakazu Kamitani, Tsukasa Kakehi, Yoshiyuki Fukuhara, Shunichi Yamamoto, Yosuke |
author_sort | Tohi, Yoichiro |
collection | PubMed |
description | PURPOSE: We developed a simple self-checkable screening tool for chronic prostatitis (S-CP) and internally validated it to encourage men (in the general population) with possible chronic prostatitis to consult urologists. METHODS: The expert panel proposed the S-CP, which comprises three domains: Area of pain or discomfort (6 components), accompanying Symptom (6 components), and Trigger for symptom flares (4 components). We employed logistic regression to predict chronic prostatitis prevalence with the S-CP. We evaluated the predictive performance using data from a representative national survey of Japanese men aged 20 to 84. We calculated the optimism-adjusted area under the curve using bootstrapping. We assessed sensitivity/specificity, likelihood ratio, and predictive value for each cutoff of the S-CP. RESULTS: Data were collected for 5,010 men—71 (1.4%) had a chronic prostatitis diagnosis. The apparent and adjusted area under the curve for the S-CP was 0.765 [95% confidence interval (CI) 0.702, 0.829] and 0.761 (0.696, 0.819), respectively. When the cutoff was two of the three domains being positive, sensitivity and specificity were 62.0% (95% CI 49.7, 73.2) and 85.4% (95% CI 84.4, 86.4), respectively. The positive/negative likelihood ratios were 4.2 (95% CI 3.5, 5.2) and 0.45 (95% CI 0.33, 0.60), respectively. The positive/negative predictive values were 5.7 (95% CI 4.2, 7.6) and 99.4 (95% CI 99.1, 99.6), respectively. CONCLUSION: The reasonable predictive performance of the S-CP indicated that patients (in the general population) with chronic prostatitis were screened as a first step. Further research would develop another tool for diagnostic support in actual clinical settings. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s00345-023-04574-x. |
format | Online Article Text |
id | pubmed-10582131 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Springer Berlin Heidelberg |
record_format | MEDLINE/PubMed |
spelling | pubmed-105821312023-10-19 Development and internal validation of a screening tool for chronic prostatitis (S-CP) Tohi, Yoichiro Hijikata, Yasukazu Sugimoto, Mikio Kuroda, Hideya Takei, Mineo Matsuki, Takakazu Kamitani, Tsukasa Kakehi, Yoshiyuki Fukuhara, Shunichi Yamamoto, Yosuke World J Urol Original Article PURPOSE: We developed a simple self-checkable screening tool for chronic prostatitis (S-CP) and internally validated it to encourage men (in the general population) with possible chronic prostatitis to consult urologists. METHODS: The expert panel proposed the S-CP, which comprises three domains: Area of pain or discomfort (6 components), accompanying Symptom (6 components), and Trigger for symptom flares (4 components). We employed logistic regression to predict chronic prostatitis prevalence with the S-CP. We evaluated the predictive performance using data from a representative national survey of Japanese men aged 20 to 84. We calculated the optimism-adjusted area under the curve using bootstrapping. We assessed sensitivity/specificity, likelihood ratio, and predictive value for each cutoff of the S-CP. RESULTS: Data were collected for 5,010 men—71 (1.4%) had a chronic prostatitis diagnosis. The apparent and adjusted area under the curve for the S-CP was 0.765 [95% confidence interval (CI) 0.702, 0.829] and 0.761 (0.696, 0.819), respectively. When the cutoff was two of the three domains being positive, sensitivity and specificity were 62.0% (95% CI 49.7, 73.2) and 85.4% (95% CI 84.4, 86.4), respectively. The positive/negative likelihood ratios were 4.2 (95% CI 3.5, 5.2) and 0.45 (95% CI 0.33, 0.60), respectively. The positive/negative predictive values were 5.7 (95% CI 4.2, 7.6) and 99.4 (95% CI 99.1, 99.6), respectively. CONCLUSION: The reasonable predictive performance of the S-CP indicated that patients (in the general population) with chronic prostatitis were screened as a first step. Further research would develop another tool for diagnostic support in actual clinical settings. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s00345-023-04574-x. Springer Berlin Heidelberg 2023-09-15 2023 /pmc/articles/PMC10582131/ /pubmed/37712967 http://dx.doi.org/10.1007/s00345-023-04574-x Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . |
spellingShingle | Original Article Tohi, Yoichiro Hijikata, Yasukazu Sugimoto, Mikio Kuroda, Hideya Takei, Mineo Matsuki, Takakazu Kamitani, Tsukasa Kakehi, Yoshiyuki Fukuhara, Shunichi Yamamoto, Yosuke Development and internal validation of a screening tool for chronic prostatitis (S-CP) |
title | Development and internal validation of a screening tool for chronic prostatitis (S-CP) |
title_full | Development and internal validation of a screening tool for chronic prostatitis (S-CP) |
title_fullStr | Development and internal validation of a screening tool for chronic prostatitis (S-CP) |
title_full_unstemmed | Development and internal validation of a screening tool for chronic prostatitis (S-CP) |
title_short | Development and internal validation of a screening tool for chronic prostatitis (S-CP) |
title_sort | development and internal validation of a screening tool for chronic prostatitis (s-cp) |
topic | Original Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10582131/ https://www.ncbi.nlm.nih.gov/pubmed/37712967 http://dx.doi.org/10.1007/s00345-023-04574-x |
work_keys_str_mv | AT tohiyoichiro developmentandinternalvalidationofascreeningtoolforchronicprostatitisscp AT hijikatayasukazu developmentandinternalvalidationofascreeningtoolforchronicprostatitisscp AT sugimotomikio developmentandinternalvalidationofascreeningtoolforchronicprostatitisscp AT kurodahideya developmentandinternalvalidationofascreeningtoolforchronicprostatitisscp AT takeimineo developmentandinternalvalidationofascreeningtoolforchronicprostatitisscp AT matsukitakakazu developmentandinternalvalidationofascreeningtoolforchronicprostatitisscp AT kamitanitsukasa developmentandinternalvalidationofascreeningtoolforchronicprostatitisscp AT kakehiyoshiyuki developmentandinternalvalidationofascreeningtoolforchronicprostatitisscp AT fukuharashunichi developmentandinternalvalidationofascreeningtoolforchronicprostatitisscp AT yamamotoyosuke developmentandinternalvalidationofascreeningtoolforchronicprostatitisscp |